• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过减小回路体积,体外生命支持期间血液制品使用量减少。

Decreased blood product usage during extracorporeal life support with reduced circuit volumes.

作者信息

Addison Samuel D, Buck Marcia L, Fang Gary Y, Gangemi James J, Kaufman David A

机构信息

Department of Pediatrics, University of Virginia Children's Hospital, Charlottesville, Virginia.

Department of Pharmacy Services, University of Virginia Children's Hospital, Charlottesville, Virginia.

出版信息

Transfusion. 2017 Jun;57(6):1391-1395. doi: 10.1111/trf.14076. Epub 2017 Mar 16.

DOI:10.1111/trf.14076
PMID:28301052
Abstract

BACKGROUND

Activation and consumption of platelets (PLT) and clotting factors along with hemolysis occurs when blood contacts the extracorporeal life support (ECLS) circuit and its components.

STUDY DESIGN AND METHODS

The objective was to examine the effects of reducing ECLS circuit volume by decreasing tubing length and changing components on blood product usage in neonatal and pediatric patients. Blood product administration was analyzed in 40 consecutive patients who required ECLS for respiratory or cardiac failure before (PRE) and after (POST) changes in circuit design and components.

RESULTS

The total circuit volume was reduced from 500 mL (PRE) to 275 mL (POST). In the POST group, total blood product volume usage was 58% lower compared to the PRE group (81 mL/kg/day vs. 191 mL/kg/day, p = 0.003), 65% lower for fresh-frozen plasma (FFP; 15 mL/kg/day vs. 43 mL/kg/day, p = 0.001), and PLT volumes trended lower. In the subgroup of infants with respiratory or cardiac failure, there was a 55% reduction of a total blood product replacement (61 mL/kg/day vs. 136 mL/kg/day, p = 0.008), red blood cell (RBC) use was 61% lower (28 mL/kg/day vs. 71 mL/kg/day, p < 0.049), and there was a 73% reduction in FFP use (11 mL/kg/day vs. 41 mL/kg/day, p < 0.001). In the subgroup of postoperative infants, there was a 25% decrease in RBC use (86 mL/kg/day vs. 115 mL/kg/day, p = 0.03).

CONCLUSION

Decreasing the ECLS circuit volume by reducing the tubing length and changing the components was associated with a significant reduction in blood product usage.

摘要

背景

当血液与体外生命支持(ECLS)回路及其组件接触时,血小板(PLT)和凝血因子会被激活并消耗,同时会发生溶血。

研究设计与方法

目的是研究通过缩短管路长度和更换组件来减少ECLS回路容积对新生儿和儿科患者血液制品使用的影响。对40例因呼吸或心力衰竭而需要ECLS的连续患者在回路设计和组件改变之前(PRE)和之后(POST)的血液制品使用情况进行了分析。

结果

总回路容积从500 mL(PRE)降至275 mL(POST)。在POST组中,血液制品总体积使用量比PRE组低58%(81 mL/kg/天 vs. 191 mL/kg/天,p = 0.003),新鲜冰冻血浆(FFP)低65%(15 mL/kg/天 vs. 43 mL/kg/天,p = 0.001),PLT体积呈下降趋势。在呼吸或心力衰竭的婴儿亚组中,血液制品总替代量减少了55%(61 mL/kg/天 vs. 136 mL/kg/天,p = 0.008),红细胞(RBC)使用量低61%(28 mL/kg/天 vs. 71 mL/kg/天,p < 0.049),FFP使用量减少了73%(11 mL/kg/天 vs. 41 mL/kg/天,p < 0.001)。在术后婴儿亚组中,RBC使用量减少了25%(86 mL/kg/天 vs. 115 mL/kg/天,p = 0.03)。

结论

通过缩短管路长度和更换组件来减少ECLS回路容积与血液制品使用量的显著减少相关。

相似文献

1
Decreased blood product usage during extracorporeal life support with reduced circuit volumes.通过减小回路体积,体外生命支持期间血液制品使用量减少。
Transfusion. 2017 Jun;57(6):1391-1395. doi: 10.1111/trf.14076. Epub 2017 Mar 16.
2
Laboratory Evaluation of Hemolysis and Systemic Inflammatory Response in Neonatal Nonpulsatile and Pulsatile Extracorporeal Life Support Systems.新生儿非搏动性和搏动性体外膜肺氧合系统中溶血和全身炎症反应的实验室评估
Artif Organs. 2015 Sep;39(9):774-81. doi: 10.1111/aor.12466. Epub 2015 May 1.
3
Impact of tubing length on hemodynamics in a simulated neonatal extracorporeal life support circuit.管长对模拟新生儿体外生命支持回路中血液动力学的影响。
Artif Organs. 2010 Nov;34(11):1003-9. doi: 10.1111/j.1525-1594.2010.01132.x.
4
Does an Open Recirculation Line Affect the Flow Rate and Pressure in a Neonatal Extracorporeal Life Support Circuit With a Centrifugal or Roller Pump?开放循环管路会影响配备离心式或滚压泵的新生儿体外膜肺氧合(ECMO)回路中的流速和压力吗?
Artif Organs. 2017 Jan;41(1):70-75. doi: 10.1111/aor.12786. Epub 2016 Nov 15.
5
Evaluation of conventional nonpulsatile and novel pulsatile extracorporeal life support systems in a simulated pediatric extracorporeal life support model.在模拟小儿体外膜肺氧合模型中对传统非搏动性和新型搏动性体外生命支持系统的评估。
Artif Organs. 2015 Jan;39(1):E1-9. doi: 10.1111/aor.12290. Epub 2014 Mar 24.
6
Extracorporeal life support after cardiac surgery in children: outcomes from a single institution.体外生命支持在小儿心脏手术后的应用:单中心结果。
Artif Organs. 2014 Jan;38(1):34-40. doi: 10.1111/aor.12191. Epub 2013 Oct 14.
7
Pediatric and neonatal extracorporeal life support technology component utilization: are US clinicians implementing new technology?儿科和新生儿体外生命支持技术组件的使用:美国临床医生是否在采用新技术?
Artif Organs. 2012 Jul;36(7):607-15. doi: 10.1111/j.1525-1594.2012.01445.x. Epub 2012 May 25.
8
Impact of Pulsatility and Flow Rates on Hemodynamic Energy Transmission in an Adult Extracorporeal Life Support System.搏动性和流速对成人体外膜肺氧合系统中血流动力学能量传递的影响
Artif Organs. 2015 Jul;39(7):E127-37. doi: 10.1111/aor.12484. Epub 2015 Apr 20.
9
Early clinical outcomes of new pediatric extracorporeal life support system (Endumo (2000) in neonates and infants.新型儿科体外生命支持系统(Endumo (2000))在新生儿和婴儿中的早期临床结果。
J Artif Organs. 2013 Sep;16(3):267-72. doi: 10.1007/s10047-013-0713-5. Epub 2013 May 30.
10
The use of an extracorporeal membrane oxygenation anticoagulation laboratory protocol is associated with decreased blood product use, decreased hemorrhagic complications, and increased circuit life.使用体外膜肺氧合抗凝实验室方案与减少血液制品使用、减少出血并发症和增加回路寿命有关。
Pediatr Crit Care Med. 2015 Jan;16(1):66-74. doi: 10.1097/PCC.0000000000000278.

引用本文的文献

1
Causes of red blood cell loss during extracorporeal membrane oxygenation.体外膜肺氧合过程中红细胞丢失的原因。
Transfusion. 2023 May;63(5):933-941. doi: 10.1111/trf.17246. Epub 2023 Jan 27.